EP3820482A4 - Formulations de réduction de tumeur et leurs procédés d'utilisation - Google Patents

Formulations de réduction de tumeur et leurs procédés d'utilisation Download PDF

Info

Publication number
EP3820482A4
EP3820482A4 EP19841949.1A EP19841949A EP3820482A4 EP 3820482 A4 EP3820482 A4 EP 3820482A4 EP 19841949 A EP19841949 A EP 19841949A EP 3820482 A4 EP3820482 A4 EP 3820482A4
Authority
EP
European Patent Office
Prior art keywords
methods
tumor reduction
formulations
reduction formulations
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19841949.1A
Other languages
German (de)
English (en)
Other versions
EP3820482A1 (fr
Inventor
Steven Hoffman
John Rothman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tyme Inc
Original Assignee
Tyme Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tyme Inc filed Critical Tyme Inc
Publication of EP3820482A1 publication Critical patent/EP3820482A1/fr
Publication of EP3820482A4 publication Critical patent/EP3820482A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
EP19841949.1A 2018-07-09 2019-07-02 Formulations de réduction de tumeur et leurs procédés d'utilisation Withdrawn EP3820482A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862695613P 2018-07-09 2018-07-09
PCT/US2019/040264 WO2020023191A1 (fr) 2018-07-09 2019-07-02 Formulations de réduction de tumeur et leurs procédés d'utilisation

Publications (2)

Publication Number Publication Date
EP3820482A1 EP3820482A1 (fr) 2021-05-19
EP3820482A4 true EP3820482A4 (fr) 2022-03-23

Family

ID=75267393

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19841949.1A Withdrawn EP3820482A4 (fr) 2018-07-09 2019-07-02 Formulations de réduction de tumeur et leurs procédés d'utilisation

Country Status (11)

Country Link
EP (1) EP3820482A4 (fr)
JP (1) JP2021530482A (fr)
KR (1) KR20220098082A (fr)
CN (1) CN112584841A (fr)
AU (1) AU2019309757A1 (fr)
BR (1) BR112021000279A8 (fr)
CA (1) CA3105717A1 (fr)
EA (1) EA202190201A1 (fr)
IL (1) IL280000A (fr)
PH (1) PH12021550033A1 (fr)
WO (1) WO2020023191A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021022784A2 (pt) 2019-05-14 2022-03-22 Tyme Inc Composições e métodos para tratamento do câncer
CN114945374A (zh) * 2019-12-09 2022-08-26 迪美公司 药物组合物和方法
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080306137A1 (en) * 2006-02-20 2008-12-11 Beijing Century Biocom Pharmaceutical Technology Co., Ltd. Pharmaceutical compositions comprising docetaxel and methods for preparation thereof
WO2017160895A1 (fr) * 2016-03-15 2017-09-21 Tyme, Inc. Compositions pharmaceutiques pour le traitement du cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1713443A2 (fr) * 2004-01-29 2006-10-25 Baxter International Inc. Nanosuspensions d'agents antiretroviraux permettant d'ameliorer l'administration dans le systeme nerveux central
WO2006099685A1 (fr) * 2005-03-24 2006-09-28 Medical Therapies Limited Methode de prevention ou de traitement de carcinomes
WO2016007741A1 (fr) * 2014-07-11 2016-01-14 The Regents Of The University Of California Anticorps à internalisation rapide dépendants de la macropinocytose et sélectifs de tumeurs
US9687528B2 (en) * 2014-12-23 2017-06-27 Steven Hoffman Transdermal formulations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080306137A1 (en) * 2006-02-20 2008-12-11 Beijing Century Biocom Pharmaceutical Technology Co., Ltd. Pharmaceutical compositions comprising docetaxel and methods for preparation thereof
WO2017160895A1 (fr) * 2016-03-15 2017-09-21 Tyme, Inc. Compositions pharmaceutiques pour le traitement du cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020023191A1 *

Also Published As

Publication number Publication date
EA202190201A1 (ru) 2021-04-09
CN112584841A (zh) 2021-03-30
IL280000A (en) 2021-03-01
KR20220098082A (ko) 2022-07-11
BR112021000279A2 (pt) 2021-04-06
JP2021530482A (ja) 2021-11-11
PH12021550033A1 (en) 2021-09-20
WO2020023191A1 (fr) 2020-01-30
AU2019309757A1 (en) 2021-03-04
BR112021000279A8 (pt) 2021-04-20
CN112584841A8 (zh) 2021-06-18
EP3820482A1 (fr) 2021-05-19
CA3105717A1 (fr) 2020-01-30

Similar Documents

Publication Publication Date Title
EP3775203A4 (fr) Compositions d'oligonucléotides et leurs procédés d'utilisation
EP3790596A4 (fr) Compositions d'oligonucléotides et leurs procédés d'utilisation
EP3684364A4 (fr) Pyridazinones et leurs procédés d'utilisation
EP3894392A4 (fr) Compositions et procédés pour le traitement du cancer
EP3749344A4 (fr) Procédés d'utilisation thérapeutique d'exosomes et d'arn y
EP3873387A4 (fr) Dispositifs de mise en prise avec le corps et procédés d'utilisation
EP3752166A4 (fr) Agents de liaison trialcyne et procédés d'utilisation
EP3886853A4 (fr) Composés diarylhydantoine et leurs procédés d'utilisation
EP3740576A4 (fr) Compositions thérapeutiques et leurs procédés de préparation et d'utilisation
EP3870203A4 (fr) Associations thérapeutiques de tdfrp et d'agents complémentaires et méthodes d'utilisation
EP3852533A4 (fr) Pyridazinones et leurs procédés d'utilisation
IL280000A (en) Formulations for reducing tumors and methods of using them
EP3829307A4 (fr) Compositions de bismuth-thiol et méthodes d'utilisation
EP3678701A4 (fr) Compositions protéiques thérapeutiques et procédés de préparation et d'utilisation de celles-ci
EP3638331A4 (fr) Compositions de tissu tridimensionnel et procédés d'utilisation
EP3784148A4 (fr) Implants et procédés d'utilisation et d'assemblage
EP3675871A4 (fr) Compositions et méthodes de traitement de maladies fibrotiques
EP3941475A4 (fr) Pyridazinones et leurs procédés d'utilisation
EP3960766A4 (fr) Agent thérapeutique anti-tumeur et son utilisation
EP4037715A4 (fr) Conjugués protéine-macromolécule et leurs méthodes d'utilisation
EP3758633A4 (fr) Implants et procédés d'utilisation et d'assemblage
EP3749691A4 (fr) Agents de liaison à angptl8 et leurs méthodes d'utilisation
AU2018292381A1 (en) Cosmetic compositions and methods of use
EP3765485A4 (fr) Immuno-exosomes et leurs procédés d'utilisation
EP3820492A4 (fr) Apmv et utilisations associées pour le traitement du cancer

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210203

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220223

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALI20220217BHEP

Ipc: A61K 47/28 20060101ALI20220217BHEP

Ipc: A61K 47/22 20060101ALI20220217BHEP

Ipc: A61K 47/10 20170101ALI20220217BHEP

Ipc: A61K 45/06 20060101ALI20220217BHEP

Ipc: A61K 31/575 20060101ALI20220217BHEP

Ipc: A61K 9/00 20060101ALI20220217BHEP

Ipc: A61K 31/4015 20060101ALI20220217BHEP

Ipc: A61K 31/08 20060101ALI20220217BHEP

Ipc: A61K 38/17 20060101ALI20220217BHEP

Ipc: A61K 38/00 20060101ALI20220217BHEP

Ipc: A61K 31/7088 20060101AFI20220217BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20230310